The Role of Clinical and Cost Information in Medicaid Pharmacy Benefit Decisions: Experience in Seven States
This policy brief provides perspective on the potential for using comparative effectiveness research in Medicaid pharmacy programs by looking at seven states to determine how they currently evaluate relative clinical and cost information about prescription drugs when making coverage decisions for their Medicaid pharmacy benefits. The brief was prepared by researchers at the Foundation’s Kaiser Commission on Medicaid and the Uninsured and Avalere Health.
Policy Brief (.pdf)
also of interest
- Medicaid Reforms to Expand Coverage, Control Costs and Improve Care: Results from a 50-State Medicaid Budget Survey for State Fiscal Years 2015 and 2016
- The Medicare Part D Prescription Drug Benefit
- Medicare Part D at Ten Years: The 2015 Marketplace and Key Trends, 2006-2015
- Medicaid in an Era of Health & Delivery System Reform: Results from a 50-State Medicaid Budget Survey for State Fiscal Years 2014 and 2015